CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 27, 2014		Jun. 28, 2013
Cash flows from operating activities:
Net earnings	$ 297,838		$ 320,902
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	30,054		33,915
Tax benefits from exercises of share-based payment awards	9,882		10,407
Excess tax benefits from share-based compensation	(9,850)		(9,570)
Depreciation	42,717		44,614
Amortization of intangible assets	3,259		3,295
Impairment of a privately-held equity investment	7,725
Deferred taxes	(4,689)		5,130
Provision for doubtful accounts receivable	5,662		4,814
Income from equity investment in affiliate	(99)		(2,459)
Other, net	(1,651)		(908)
Changes in assets and liabilities, net of effect of acquisition:
Accounts receivable	(67,947)		18,663
Inventories	(49,060)		(80,398)
Prepaid expenses and other assets	(22,147)		(22,637)
Accounts payable	(14,020)		(261)
Accrued expenses and other liabilities	(14,768)		(78,035)
Deferred revenues and advance payments from customers	42,683		52,784
Net cash provided by operating activities	255,589		300,256
Cash flows from investing activities:
Purchases of property, plant and equipment	(63,229)		(56,688)
Investment in available-for-sale corporate debt securities	(40,692)		(7,554)
Sale of a portion of investment in available-for-sale corporate debt security	38,075
Acquisitions of businesses, net of cash acquired	(15,500)
Notes receivable	(5,500)		(10,000)
Net amounts paid to deferred compensation plan trust account			(15)
Other	642		(129)
Net cash used in investing activities	(86,204)		(74,386)
Cash flows from financing activities:
Repurchases of common stock	(417,245)		(289,099)
Proceeds from issuance of common stock to employees	84,107		104,464
Excess tax benefits from share-based compensation	9,850		9,570
Employees' taxes withheld and paid for restricted stock and restricted stock units	(8,664)		(9,526)
Net borrowings under credit facility agreements	29,553		14,935
Repayments under term loan facility and other bank borrowings	(56,250)
Other	(616)		(935)
Net cash used in financing activities	(359,265)		(170,591)
Effects of exchange rate changes on cash and cash equivalents	(1,994)		5,718
Net increase/(decrease) in cash and cash equivalents	(191,874)		60,997
Cash and cash equivalents at beginning of period	1,117,861	[1]	704,570
Cash and cash equivalents at end of period	$ 925,987		$ 765,567

[1] The condensed consolidated balance sheet as of September 27, 2013 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.